☆ 3.8 Article

Mapping of familial hypercholesterolemia and dyslipidemias basic management infrastructure in Pakistan: a cross-sectional study

LANCET REGIONAL HEALTH - SOUTHEAST ASIA (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Medicine, General & Internal

Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study

Tycho R. Tromp et al.

Summary: Patients with homozygous familial hypercholesterolaemia (HoFH) globally face issues of late diagnosis, under-treatment, and high risk of premature ASCVD. The use of multiple lipid-lowering therapy regimens is associated with lower LDL cholesterol levels and better outcomes. Significant global disparities exist in treatment regimens, control of LDL cholesterol levels, and cardiovascular event-free survival.

LANCET (2022)

添加到收藏夹

Editorial Material Cardiac & Cardiovascular Systems

Screening in children for familial hypercholesterolaemia: start now

Urh Groselj et al.

EUROPEAN HEART JOURNAL (2022)

添加到收藏夹

Article Genetics & Heredity

Universal screening for familial hypercholesterolemia in 2 populations

Ursa Sustar et al.

Summary: This study assessed the performance of two different screening programs for diagnosing familial hypercholesterolemia (FH) in children and found that the opt-out screening strategy was more advantageous than the opt-in strategy, as it could effectively detect FH patients and their family members.

GENETICS IN MEDICINE (2022)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Paediatric familial hypercholesterolaemia screening in Europe: public policy background and recommendations

Samuel S. Gidding et al.

Summary: Familial hypercholesterolaemia (FH) is often overlooked and undertreated in Europe, resulting in increased risk of premature heart disease. Early treatment is effective in preventing heart disease and cost-effective. The European Commission Public Health Best Practice Portal recognizes FH screening as an effective strategy. Model programs in Europe employ cascade screening, universal screening, opportunistic screening, or a combination of these approaches to identify young individuals with FH. Recommendations to improve FH identification emphasize the need for screening programs in every country, adapted to fit the healthcare system, with financial support from governments and further research for optimization.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Access to Essential Cardiovascular Medicines in Pakistan: A National Survey on the Availability, Price, and Affordability, Using WHO/HAI Methodology

Amna Saeed et al.

Summary: This national survey in Pakistan revealed low availability of cardiovascular disease medicines in both public and private sectors, with high prices that pose a significant burden on the lowest paid government workers. Compared to other low and middle income countries, the affordability of standard cardiovascular drug treatment in Pakistan was found to be low.

FRONTIERS IN PHARMACOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Antonio J. Vallejo-Vaz et al.

Summary: This study characterized the adult population with heterozygous familial hypercholesterolaemia using data from the FHSC global registry, highlighting the challenges in prevention and management of the condition. Early detection and greater use of combination therapies are needed to reduce the global burden of familial hypercholesterolaemia.

LANCET (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

Francois Mach et al.

EUROPEAN HEART JOURNAL (2020)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action

Katherine A. Wilemon et al.

JAMA CARDIOLOGY (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Knowledge, awareness and practice regarding familial hypercholesterolaemia among primary care physicians in Malaysia: The importance of professional training

Ahmad Baihaqi Azraii et al.

ATHEROSCLEROSIS (2018)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Universal screening for familial hypercholesterolemia in children: The Slovenian model and literature review

Urh Groselj et al.

ATHEROSCLEROSIS (2018)

添加到收藏夹

Article Medicine, General & Internal

Familial hypercholesterolemia: An under-diagnosed and under-treated disease. Survey of 495 physicians

Sophie Beliard et al.

PRESSE MEDICALE (2018)

添加到收藏夹

Editorial Material Cardiac & Cardiovascular Systems

Genetic testing for familial hypercholesterolaemia is essential in individuals with high LDL cholesterol: who does it in the world?

Borge G. Nordestgaard et al.

EUROPEAN HEART JOURNAL (2017)

添加到收藏夹

Article Medicine, General & Internal

An enquiry based on a standardised questionnaire into knowledge, awareness and preferences concerning the care of familial hypercholesterolaemia among primary care physicians in the Asia-Pacific region: the Ten Countries Study

Jing Pang et al.

BMJ OPEN (2017)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment

Albert Wiegman et al.

EUROPEAN HEART JOURNAL (2015)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Familial Hypercholesterolemia: An Under-recognized but Significant Concern in Cardiology Practice

JoAnne M. Foody

CLINICAL CARDIOLOGY (2014)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.